Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001356090-25-000011
Filing Date
2025-04-28
Accepted
2025-04-28 17:23:16
Documents
17
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A pgen-20241231.htm   iXBRL 10-K/A 900125
2 EX-31.3 pgen-20241231xexx313.htm EX-31.3 4211
3 EX-31.4 pgen-20241231xexx314.htm EX-31.4 4277
  Complete submission text file 0001356090-25-000011.txt   1461260

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pgen-20241231.xsd EX-101.SCH 1899
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pgen-20241231_lab.xml EX-101.LAB 133708
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pgen-20241231_pre.xml EX-101.PRE 71734
19 EXTRACTED XBRL INSTANCE DOCUMENT pgen-20241231_htm.xml XML 8048
Mailing Address 20374 SENECA MEADOWS PARKWAY GERMANTOWN MD 20876
Business Address 20374 SENECA MEADOWS PARKWAY GERMANTOWN MD 20876 301-556-9900
PRECIGEN, INC. (Filer) CIK: 0001356090 (see all company filings)

EIN.: 000000000 | State of Incorp.: VA | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-36042 | Film No.: 25881636
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)